Inactive Instrument

Vican Resources Inc Stock Other OTC

Equities

US9256061055

Advanced Medical Equipment & Technology

End-of-day quote Other OTC
- USD - Intraday chart for Vican Resources Inc
Sales 2017 - Sales 2018 0.04 Capitalization 77.97M
Net income 2017 - Net income 2018 -5M EV / Sales 2017 -
Net Debt 2017 37.06K Net cash position 2018 58.56K EV / Sales 2018 2,167,635,443 x
P/E ratio 2017
21.4 x
P/E ratio 2018
-12.5 x
Employees -
Yield 2017 *
-
Yield 2018
-
Free-Float 100%
More Fundamentals * Assessed data
Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC. CI
Frélii, Inc. announced that it has received $0.203 million in funding CI
Frélii, Inc. entered into share purchase agreement to acquire 25% shares of Genecor AI Inc. for $0.94 million from Helix Investment Partners LLC. CI
Frélii, Inc. announced that it has received $0.154 million in funding CI
Frélii, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
Frélii, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
Frelii, Inc. Announces Resignation of Leslie Norris as Chief Operating Officer; Opens Its First Wholly Owned Subsidiary, Frelii Canada Inc. in Mississauga, Ontario, Canada CI
Frélii, Inc. Inks Agreement with Orn Health Inc. to Support Healthcare Franchisee Partners Incorporating Pharmacogentics Into Patient Treatment CI
Frelii Inc. Announces Executive Changes CI
Frélii, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019 CI
Frélii, Inc. Signs Contract and Licensing Agreement with Optivida Health CI
Frélii, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018 CI
Frélii, Inc. Announces Address Change CI
NewPath Health Care Solutions, Inc Frélii, Inc. Mercator Biologic, Inc. and True DNA Story, LLC Enter into Memorandum of Understanding to Strategically Explore the Full Capabilities of Each Company CI
Frelii Inc. Signs Memorandum of Understanding with NewPath Health Care Solutions, Inc., Mercator Biologic, Inc. and True DNA Story, LLC CI
More news
Managers TitleAgeSince
Chief Executive Officer 40 17-04-04
Chief Tech/Sci/R&D Officer 49 18-05-14
Chief Tech/Sci/R&D Officer 47 18-03-26
Members of the board TitleAgeSince
Chief Executive Officer 40 17-04-04
Director/Board Member 53 17-12-31
65 -
More insiders
Frelii, Inc. provides Web-based nutrition and fitness programs based on users’ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies users’ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Company’s site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.
More about the company